Dr. Giordano Featured in Forbes Article on COVID-19 Antibody Tests in Italy and USA
Reporter: Stephen J. Williams, PhD
via Dr. Giordano Featured in Forbes Article on COVID-19 Antibody Tests in Italy and USA
Posted in Biomarkers: Inflammation, Cancer Researchers Fighting COVID-19, Coronavirus Gene Expression, COVID-19, COVID-19, COVID-19 effects on Human Heart, COVID-19: Pandemic Surgery Guidance, Diagnostic Immunology, Diagnostics and Lab Tests, Economic Impact of Coronavirus Pandemic, Evolution of Biology Through Culture, Frontiers in Cardiology and Cardiovascular Disorders, Immune-Mediation (independent immunopathology: lung and reticuloendothelial system), Interviews with Key Opinion Leaders (KOLs), number of asymptomatic infections, Population Health Management, Population Health Management, Genetics & Pharmaceutical, SAR-Cov-2 a vasculotropic (blood vessels) RNA Virus, Scientific Publishing, Systemic Inflammatory Diseases as CVD Risk, tagged #italy, antibody tests, COVID-19, diagnostic antibody, diagnostic testing, Forbes, forbes magazine, immunoassay, key opinion leaders, SARS-CoV-2, scientific leaders on May 10, 2020| Leave a Comment »
Dr. Giordano Featured in Forbes Article on COVID-19 Antibody Tests in Italy and USA
Reporter: Stephen J. Williams, PhD
via Dr. Giordano Featured in Forbes Article on COVID-19 Antibody Tests in Italy and USA